======= VWA2 =======
== Gene Information ==
* **Official Symbol**: VWA2
* **Official Name**: von Willebrand factor A domain containing 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=340706|340706]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q5GFL6|Q5GFL6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=VWA2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VWA2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/618281|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|EGF|
|VWA|
|calcium-independent cell-matrix adhesion|
|growth plate cartilage chondrocyte morphogenesis|
|chondrocyte morphogenesis|
|chondrocyte morphogenesis involved in endochondral bone morphogenesis|
|growth plate cartilage morphogenesis|
|growth plate cartilage chondrocyte differentiation|
|chondrocyte development involved in endochondral bone morphogenesis|
|cartilage morphogenesis|
|chondrocyte differentiation involved in endochondral bone morphogenesis|
|growth plate cartilage development|
|endochondral bone growth|
|chondrocyte development|
|cartilage development involved in endochondral bone morphogenesis|
|bone growth|
|regulation of insulin receptor signaling pathway|
|regulation of cellular response to insulin stimulus|
|endochondral bone morphogenesis|
|chondrocyte differentiation|
|basement membrane|
|organ growth|
|bone morphogenesis|
|cell-matrix adhesion|
|cartilage development|
|cell-substrate adhesion|
|bone development|
|connective tissue development|
|extracellular matrix|
|skeletal system morphogenesis|
|protein homooligomerization|
|collagen-containing extracellular matrix|
|developmental growth|
|growth|
|skeletal system development|
|protein complex oligomerization|
|cell morphogenesis involved in differentiation|
|tissue morphogenesis|
|calcium ion binding|
|cell morphogenesis|
|cellular component morphogenesis|
|cell adhesion|
|biological adhesion|
|animal organ morphogenesis|
|identical protein binding|
|protein-containing complex assembly|
|extracellular space|
|cell development|
|tissue development|
|protein-containing complex subunit organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-1.96|
|[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.71|
|[[:results:exp406|Thalidomide 20μM R07 exp406]]|1.8|
^Gene^Correlation^
|[[:human genes:p:prim1|PRIM1]]|0.405|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8236
* **Expression level (log2 read counts)**: -1.95
{{:chemogenomics:nalm6 dist.png?nolink |}}